This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Applegate, K. G. Articles by Pellis, N. R. Search for Related Content PubMed PubMed Citation Articles by Applegate, K. G. Articles by Pellis, N. R.

In Vitro Migration of Lymphocytes through Collagen Matrix: Arrested Locomotion in Tumor-infiltrating Lymphocytes¹

Department of General Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Antitumor immunity requires (a) extravasation of lymphocytes from the blood stream to interstitium, (b) locomotion through extracellular matrix to the site of the tumor, (c) effector cell recognition of the tumor target with cell/cell contact and binding of adhesion receptors, (d) T-cell receptor binding to histocompatibility and tumor antigens, and (e) tumor cell lysis. We hypothesize that the tumor microenvironment inhibits lymphocyte locomotion through extracellular matrix as one mechanism by which tumors may avert host defense. Lymphocyte locomotion was investigated in vitro using a three-dimensional collagen gel model. Fresh tumor-infiltrating lymphocytes (TIL) were obtained by enzymatic digestion of melanomas and renal cell carcinoma, and mononuclear cells were isolated by discontinuous Ficoll-Hypaque gradient. The lymphocytes were analyzed for motility from a point of origin between basal and overlay layers of collagen gel. Results showed that TIL migration was almost completely inhibited, compared with migration of normal and cancer patient peripheral blood leukocytes and lymphocytes from lymph nodes. Short-term (24-h) exposure of lymphocytes to cytokines during the assay in the collagen gel matrix had no effect on locomotor ability. Long-term (19, 30, or 35 days) culture of TIL in 200 units/ml of interleukin 2 reinstated locomotor ability. Short-term exposure of any of the lymphocyte populations to interleukin 1-, interleukin 1-ß, interleukin 2, interleukin 3, interleukin 4, -interferon, or -interferon had no effect on migration. Thus, TIL display a uniquely arrested ability to locomote through collagen gel. Inhibition of the locomotion of infiltrating effector cells is possibly a mechanism by which the tumor evades the host immune system.

¹ This work was supported by the Gillson-Longenbaugh Foundation.

² Surgical oncology fellow supported by National Cancer Institute Training Grant CA09599-02.

³ To whom requests for reprints should be addressed, at Department of General Surgery, The University of Texas M. D. Anderson Cancer Center, 1515 Holcombe Blvd., Box 174, Houston, TX 77030.

Received 4/16/90. Accepted 8/17/90.

This article has been cited by other articles:

				P. Mulders, C.-L. Tso, B. Gitlitz, R. Kaboo, A. Hinkel, S. Frand, S. Kiertscher, M. D. Roth, J. deKernion, R. Figlin, et al. Presentation of Renal Tumor Antigens by Human Dendritic Cells Activates Tumor-infiltrating Lymphocytes against Autologous Tumor: Implications for Live Kidney Cancer Vaccines Clin. Cancer Res., February 1, 1999; 5(2): 445 - 454. [Abstract] [Full Text] [PDF]

				B. Kim and A. C. Louie Surgical Resection Following Interleukin 2 Therapy for Metastatic Renal Cell Carcinoma Prolongs Remission Arch Surg, November 1, 1992; 127(11): 1343 - 1349. [Abstract] [PDF]